Table 1 Clinical characteristics of 376 ovarian cancer patients in TCGA database
Characteristics | Total |
|---|---|
N = 376 (%) | |
Age | |
< 60 | 198 (52.7) |
≥ 60 | 178 (47.3) |
FIGO stage | |
Stage I | 1 (0.3) |
Stage II | 22 (5.9) |
Stage III | 293 (78.6) |
Stage IV | 57 (15.3) |
Histologic grade | |
G1 | 1 (0.3) |
G2 | 42 (11.5) |
G3 | 322 (88.0) |
G4 | 1 (0.3) |
Recurrence | |
No | 176 (46.8) |
Yes | 200 (53.2) |
Tumor status | |
Tumor free | 71 (21.3) |
With tumor | 262 (78.7) |
Primary therapy outcome | |
PD | 27 (8.9) |
SD | 22 (7.2) |
PR | 43 (14.1) |
CR | 213 (69.8) |
Tumor residual | |
NRD | 66 (19.8) |
RD | 267 (80.2) |
Lymphatic invasion | |
No | 48 (32.4) |
Yes | 100 (67.6) |
Venous invasion | |
No | 40 (38.8) |
Yes | 63 (61.2) |
Anatomic subdivision | |
Unilateral | 101 (28.5) |
Bilateral | 253 (71.5) |
TP53 mutation | |
No | 26 (9.5) |
Yes | 248 (90.5) |
BRCA mutation | |
No | 249 (90.9) |
Yes | 25 (9.1) |
OS event | |
Alived | 146 (38.8) |
Dead | 230 (61.2) |